Meet Anisha Patel, M.D.
Anisha B. Patel, M.D.
Department of Dermatology, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Dermatology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Dermatology, The University of Texas Health Science Center at Houston, Houston, TX
Education & Training
Degree-Granting Education
| 2008 | Baylor College of Medicine, Houston, TX, USA, MD, Doctor of Medicine |
| 2002 | Rice University, Houston, TX, USA, BS, Mechanical Engineering and Materials Science |
Postgraduate Training
| 2012-2013 | Clinical Fellowship, Dermatopathology, University of Texas-Medical Branch, Galveston, TX |
| 2009-2012 | Clinical Residency, Dermatology, Oregon Health and Science University, Portland, OR |
Selected Publications
Peer-Reviewed Articles
- Karri P, Freemyer B, Aboul-Fettouh N, Patel AB, Curry JL, Rogge M. Plasma cell myeloma with immature plasma cells in the skin arising within the areas of chronic stasis dermatitis. JAAD Case Rep 7:26-29, 2021. e-Pub 2020. PMID: 33318997.
- Krauland K, Patel AB. Junctional Melanocytic Hyperplasia Overlying Benign Fibrous Papule: An Under-recognized Variant of a Common Lesion. J Cutan Pathol 47(12):1220-1223, 2020. e-Pub 2020. PMID: 32496596.
- Lee H, Jung SJ, Patel AB, Thompson JM, Qureshi A, Cho E. Racial Characteristics of Alopecia Areata in the United States. J Am Acad Dermatol 83(4):1064-1070, 2020. e-Pub 2019. PMID: 31279016.
- Messer A, Drozd B, Glitza IC, Lu H, Patel AB. Dermatomyositis associated with nivolumab therapy for melanoma: a case report and review of the literature. Dermatol Online J 26(8), 2020. e-Pub 2020. PMID: 32941716.
- Swali R, Nwannunu C, Farooq S, Wu W, Robare S, Patel A, Tyring SK. Cutaneous myoepithelioma of the foot. Int J Dermatol 59(5):e173-e174, 2020. e-Pub 2019. PMID: 31769018.
- Andrews ED, Garg N, Patel AB. A Retrospective Chart Review on Oral Retinoids as a Treatment for Epidermal Growth Factor Receptor Inhibitor and Mitogen-activated Protein Kinase Kinase Inhibitor Induced Acneiform Eruptions. J Am Acad Dermatol 82(4):998-1000, 2020. e-Pub 2019. PMID: 31604105.
- Limmer AL, Park KE, Patel AB, Huen AO. Unusual presentation of Kaposi sarcoma in an HIV-negative woman. Dermatol Online J 26(4), 2020. e-Pub 2020. PMID: 32621687.
- Nguyen JK, Schlichte MJ, Jogi R, Alikhan M, Patel AB. A case of new-onset vitiligo in a patient on tofacitinib and brief review of paradoxical presentations with other novel targeted therapies. Dermatol Online J 26(3), 2020. e-Pub 2020. PMID: 32609446.
- Patel AB, Pacha O. Skin Reactions to Immune Checkpoint Inhibitors. Adv Exp Med Biol 1244:235-246, 2020. PMID: 32301018.
- Johnson D, Patel AB, Uemura MI, Trinh VA, Jackson N, Zobniw CM, Tetzlaff MT, Hwu P, Curry JL, Diab A. IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy. Cancer Immunol Res 7(6):860-865, 2019. e-Pub 2019. PMID: 30996018.
- Doan HQ, Hu MI, Goldstein J, Piha-Paul SA, Subbiah V, Patel AB. Vandetanib photoinduced cutaneous toxicities. Cutis 103(5):E24-E29, 2019. PMID: 31233590.
- Rios A, Cen P, Dinh B, Mays SR, Patel AB. Dramatic response of nivolumab-associated psoriasiform dermatitis to etoposide. Eur J Cancer 107:97-99, 2019. e-Pub 2018. PMID: 30554075.
- Welborn M, Kubicki SL, Garg N, Patel AB. Retrospective Chart Review of Cutaneous Adverse Events Associated with Tremelimumab in 17 Patients. Am J Clin Dermatol 19(6):899-905, 2018. e-Pub 2018. PMID: 30073495.
- Kubicki SL, Welborn ME, Patel AB. Toxic epidermal necrolysis during cotherapy with Ipilimumab and Nivolumab. J Immunother & Precision Onc 1(2):79-81, 2018.
- Welborn ME, Kubicki SL, Patel AB. Pyoderma gangrenosum following initiation of immune-checkpoint inihibitor therapy. J Immunother & Precision Onc 1(2):82-4, 2018.
- Chen L, Parsons AM, Aria AB, Ciurea AM, Patel AB, Chan C, Griffin JR, Nguyen TH, Migden MR. Surgical site identification with personal digital device: A prospective pilot study. J Am Acad Dermatol 79(3):520-524, 2018. e-Pub 2018. PMID: 29524583.
- Fujii T, Colen RR, Bilen MA, Hess KR, Hajjar J, Suarez-Almazor ME, Alshawa A, Hong DS, Tsimberidou A, Janku F, Gong J, Stephen B, Subbiah V, Piha-Paul SA, Fu S, Sharma P, Mendoza T, Patel A, Thirumurthi S, Sheshadri A, Meric-Bernstam F, Naing A. Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs 36(4):638-646, 2018. e-Pub 2017. PMID: 29159766.
- Kubicki SL, Welborn ME, Garg N, Aung PP, Patel AB. Granulomatous dermatitis associated with ipilimumab therapy (ipilimumab associated granulomatous dermatitis). J Cutan Pathol 45(8):636-638, 2018. e-Pub 2018. PMID: 29704281.
- Fernandez-Flores A, Llamas-Velasco M, Saus C, Patel A, Rutten A. Microcystic adnexal carcinoma with sebaceous differentiation: Three cases. J Cutan Pathol 45(4):290-295, 2018. e-Pub 2018. PMID: 29352496.
- Chockalingam R, Aneja S, Patel AB. Primary cutaneous follicle center lymphoma mimicking folliculitis. Cutis 101(1):E30-E33, 2018. PMID: 29529119.
- Patel AB, Pacha O. Skin Reactions to Immune Checkpoint Inhibitors. Adv Exp Med Biol 995:117-129, 2018. PMID: 30539508.
- Li JY, Ivan D, Patel AB. Acral retiform purpura. Lancet 390(10110):2382, 2017. e-Pub 2017. PMID: 28890159.
- Sundaresan S, Nguyen KT, Nelson KC, Ivan D, Patel AB. Erythema multiforme major in a patient with metastatic melanoma treated with nivolumab. Dermatol Online J 23(9), 2017. e-Pub 2017. PMID: 29469720.
- Patel AB, Pacha O. Skin Reactions to Immune Checkpoint Inhibitors. Adv Exp Med Biol 995:175-184, 2017. PMID: 28321818.
- Al-Rohil RN, Torres-Cabala CA, Patel A, Tetzlaff MT, Ivan D, Nagarajan P, Curry JL, Miranda RN, Duvic M, Prieto VG, Aung PP. Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding. J Cutan Pathol 43(12):1161-1166, 2016. e-Pub 2016. PMID: 27531242.
- Jour G, Glitza IC, Ellis RM, Torres-Cabala CA, Tetzlaff MT, Li JY, Nagarajan P, Huen A, Aung PP, Ivan D, Drucker CR, Prieto VG, Rapini RP, Patel A, Curry JL. Autoimmune Dermatologic Toxicities from Immune Checkpoint Blockade with anti-PD-1 Antibody Therapy: A Report on Bullous Skin Eruptions. J Cutan Pathol 43(8):688-96, 2016. e-Pub 2016. PMID: 27086658.
- Chockalingam R, Aung P, Patel AB. Regorafenib- associated panniculitis. Dermatol Online J 22(6), 2016. e-Pub 2016. PMID: 27617607.
- Patel AB, Solomon AR, Mauro MJ, Ehst BD. Unique cutaneous reaction to second- and third- generation tyrosine kinase inhibitors for chronic myeloid leukemia. Dermatology 232(1):122-5, 2016. e-Pub 2015. PMID: 26352467.
- Patel T, Patel AB, Moody M, Kelly B, Gibson B. Tzanck smear for quick screening of transient myeloproliferative disorder in neonates with vesiculopapular eruptions. Int J Dermatol 54(7):e251-3, 2015. e-Pub 2014. PMID: 24738623.
- Cabanillas ME, Patel A, Danysh BP, Dadu R, Kopetz S, Falchook G. BRAF inhibitors in thyroid cancer: a review of efficacy and toxicity beyond melanoma. Horm Cancer 6(1):21-36, 2015. e-Pub 2014. PMID: 25467940.
- Patel AB. Postinflammatory hyperpigmentation: Review of pathogenesis, prevention, and treatment. Pigment International 1(2):59-69, 2015. e-Pub 2014.
- Goldstein J, Patel AB, Curry JL, Subbiah V, Piha-Paul S. Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case report. BMC Dermatol 15(1):2, 2015. e-Pub 2015. PMID: 25886034.
- Patel AB, Hill E, Simpson EL, Hanifin JM. Reversion of methicillin-resistant Staphylococcus aureus (MRSA) skin infections to methicillin-susceptible isolates. JAMA Dermatol 149(10):1167-71, 2013. PMID: 23945667.
- Patel AB, Kubba R, Kubba A. Clinicopathological correlation of acquired hypopigmentary disorders. Indian J Dermatol Venereol Leprol 79(3):376-82, 2013. PMID: 23619442.
- Patel AB, Kubba R, Kubba A. Clinicopathological correlation of acquired hyperpigmentary disorders. Indian J Dermatol Venereol Leprol 79(3):367-75, 2013. PMID: 23619441.
- Leitenberger JJ, Patel AB, Cushing MC, Jack AR. Resident Rounds: Part II Contact allergens relevant to dermatitis in special locations. J Drugs Dermatol 11(5):657-8, 2012.
- Patel AB, Wagle RR, Usrey MM, Thompson MT, Incavo SJ, Noble PC. Guidelines for implant placement to minimize impingement during activities of daily living after total hip arthroplasty. J Arthroplasty 25(8):1275-81.e1, 2010. e-Pub 2009. PMID: 20022449.
- Patel AB, Katta R. Allergen Profile: Neomycin. Dermatitis 19(2):E7-8, 2008. PMID: 18413103.
- Patel AB, Harting MS, Hsu S. Solid facial edema: treatment failure with oral isotretinoin monotherapy and combination oral isotretinoin and oral steroid therapy. Dermatol Online J 14(1):14, 2008. e-Pub 2008. PMID: 18319031.
- Patel AB, Rosen T. Herpes vegetans as a sign of HIV infection. Dermatol Online J 14(4):6, 2008. e-Pub 2008. PMID: 18627728.
- Patel AB, Harting MS, Smith-Zagone MJ, Hsu S. Familial basaloid follicular hamartoma: a report of one family. Dermatol Online J 14(4):14, 2008. e-Pub 2008. PMID: 18627736.
- Barrios DM, Phillips GS, Geisler AN, Trelles SR, Markova A, Noor SJ, Quigley EA, Haliasos HC, Moy AP, Schram AM, Bromberg J, Funt SA, Voss MH, Drilon A, Hellmann MD, Comen EA, Narala S, Patel AB, Wetzel M, Jung JY, Leung DYM, Lacouture ME. IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies. Ann Oncol. e-Pub 2021. PMID: 33667669.
- Keiser MF, Patel AB, Altan M. Cutaneous toxicities in lung cancer patients on immune checkpoint inhibitor therapy. Clin Lung Cancer. e-Pub 2021. PMID: 33637416.
- Karri PV, Tahseen D, Patel AB. Treatment of Checkpoint Inhibitor-Induced Vitiligo in a Patient With Metastatic Renal Cell Cancer. Dermatitis. e-Pub 2020. PMID: 33273227.